Pfizer, BioNTech coronavirus vaccine shows promise; Sherlock Biosciences to bring CRISPR COVID-19 test to doctor’s offices; Submit a cover design for MM&M’s Hall of Femme issue.
This week’s Haymarket Media Coronavirus Briefing is 1,388 words and will take you seven minutes to read.
An internal memo was sent to staff today.
The state expects to make a decision later this summer.
FDA outlines conditions to approve coronavirus vaccine; Fauci warns daily COVID-19 cases could more than double in U.S.; Join the MM&M Move Together event.
Gilead announces price for remdesivir; Bipartisan support of drug price legislation has waned; More states slow down reopening as COVID-19 cases rise.
The treatment will cost $3,120 for a five-day treatment course for a patient with private insurance in the U.S.
The holding company leaders don’t let an empty Palais des Festivals stop them from celebrating.
Justice Department asks Supreme Court to overturn ACA; States reverse reopening as virus cases climb; Submit creative to MM&M’s #CreateHealthEquity initiative.
The inside story of how one of healthcare marketing’s most important channels navigated COVID-19 – and may have emerged stronger and smarter.